Exploring the epigenetic susceptibility mechanisms of lung cancer through DNA methylation markers

Abstract

During lung carcinogenesis, different epigenetic changes occur and, among these, DNA methylation aberrations play a critical role, representing an appealing biomarker for cancer screening. In this Cancer issue, Zhao et al. systematically assessed the associations of genetically predicted DNA methylation CpGs with non–small cell lung cancer risk.